Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Latest round
Venture round
Oct 2026 · 1 mo ago
Team
1-10
employees, estimated range
Grants
$1.2M
2 grants · CORDIS
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2 Raised a round Venture round Apr 29 Raised a round Venture round Feb 27, 2025 Raised a round Venture round Jun 1, 2024 Won a grant $589k · CORDIS Jan 25, 2024 Raised a round Venture round Sep 1, 2023 Won a grant $629k · CORDIS Jul 4, 2023 Raised a round Venture round Nov 15, 2022 Raised a round Venture round Apr 5, 2022 Raised a round Venture round Jan 26, 2021 Founded per the company register
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2026 — — find-and-update.company-information.service.gov.uk
Venture round Apr 2026 — — find-and-update.company-information.service.gov.uk
Venture round Feb 2025 — — find-and-update.company-information.service.gov.uk
Grant Jun 2024 $589k — CORDIS
Venture round Jan 2024 — — find-and-update.company-information.service.gov.uk
Grant Sep 2023 $629k — CORDIS
Venture round Jul 2023 — — find-and-update.company-information.service.gov.uk
Venture round Nov 2022 — — find-and-update.company-information.service.gov.uk
Venture round Apr 2022 — — find-and-update.company-information.service.gov.uk
Registers and programsofficial lists and records that name the company
Legal entity THIRTYFIVEBIO LIMITED Companies House
Registered 26 Jan 2021
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Unified clinical AI platform integrating specialist knowledge, medical tools, and EHR data. Evidence-based, validated, built for clinicians.
Light Horse is a small molecule drug discovery company that is leading the way in a.
RetinAI201-500 employees · 6 roles
RetinAI develops solutions to generate and organize insights and knowledge to improve patient outcomes.
Bahto Biosciences develops a non-opioid small-molecule therapeutic for painful peripheral neuropathy.
Wayfinder Biosciences develops RNA-targeting small molecules for undruggable targets.
Treeline BiosciencesVenture round $200.1M · 14 mo ago · Founded 2021 · 9 roles
Treeline Biosciences is a biotechnology company developing small-molecule medicines for cancer and immune diseases.

Overview

Applying specialist knowledge to develop small molecule antagonists of genetically-validated GPCR GPR35.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Abingdon United Kingdom
HQ
1-10 est. staff

Financials

Total raised
$1.2M
Latest round
Venture - Series Unknown
Funding rounds
9
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 — Details
Venture - Series Unknown 2026 — Details
Venture - Series Unknown 2025 — Details
Grant 2024 $589k Details
Venture - Series Unknown 2024 — Details
Grant 2023 $629k Details
Venture - Series Unknown 2023 — Details
Venture - Series Unknown 2022 — Details
Venture - Series Unknown 2022 — Details